Clinical Trial Detail

NCT ID NCT01240590
Title A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland cancer

Advanced Solid Tumor

Therapies

Cisplatin + Crolibulin

Cisplatin

Age Groups: adult

No variant requirements are available.